Tetrahedral DNA Nanostructure‐Based Biomimetic Nanovesicles Attenuate Sepsis‐Associated ARDS by Suppressing Glycolysis via the BMAL1/PFKFB3 Axis
Advanced Science · 2026-06 · 13 (34)
DOI: 10.1002/advs.202523782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 20.04.2026. Verfasst von Yunlong Zhang und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine & Department of Emergency, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Sepsis, Respiratory Distress Syndrome, ARNTL Transcription Factors, Glycolysis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Key Research and Development Program of Ningxia Hui Autonomous Region.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis‐associated acute respiratory distress syndrome (SA‐ARDS) is a life‐threatening complication characterized by excessive pulmonary inflammation and pulmonary edema, lacking effective treatments. This study identifies the transcription factor BMAL1 in alveolar macrophages (AMs) as a key therapeutic target. Mechanistically, BMAL1 represses the expression of the glycolytic enzyme PFKFB3 by binding to the Pfkfb3 promoter, thereby inhibiting glycolysis, M1 polarization of AMs, and the generation of pro‐inflammatory cytokines and reactive oxygen species (ROS). Based on this regulatory mechanism, a biomimetic nanoplatform, RM@TNT, is engineered for precise SA‐ARDS therapy. Fabricated by hybridizing AM membrane‐derived nanovesicles with ROS‐responsive liposomes, the nanoplatform encapsulates tetrahedral DNA nanostructures (TNT) preloaded with nobiletin (Nob, a BMAL1 agonist) and Tuftsin (an AM‐targeting peptide). Following inhalation, the AM membrane tropism of RM@TNT ensures prolonged pulmonary retention, prompting targeted TNT release within the ROS‐rich pathological microenvironment. Tuftsin then precisely delivers TNT to AMs, where Nob is intracellularly released to activate BMAL1. This activation upregulates the BMAL1/PFKFB3 axis, suppressing AM glycolysis, inflammation, and oxidative stress. Treatment with RM@TNT resulted in significantly attenuated lung inflammation, injury, and edema, along with markedly improved survival in SA‐ARDS mice. Collectively, this multimodal, targeted metabolic reprogramming approach is a highly promising therapeutic strategy for SA‐ARDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine & Department of Emergency, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- School of Inspection, Ningxia Medical University, Yinchuan, Ningxia, China.
- School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia, China.
- Institute for Engineering Medicine, Kunming Medical University, Kunming, Yunnan, China.
- Department of Microbiology, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.
ORCID-Profile: Yunlong Zhang, Bin Li, Liying Zhan, Yuhui Liao
Förderung
- Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project
- National Natural Science Foundation of China
- Key Research and Development Program of Ningxia Hui Autonomous Region
- Natural Science Foundation of Ningxia - Outstanding Youth Program
- Guangdong Basic and Applied Basic Research Foundation
- China College Student Innovation and Entrepreneurship Training Program Project
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Zhang, Y., Li, B., Fan, Z., Yan, Y., Ma, F., He, C., Liu, S., Pan, M., Pan, Z., Wang, H., Fu, X., Wang, J., Jia, Y., Gu, Q., Jiang, D., Liu, X., Ren, B., Wang, Q., Hei, Y., …, & Liao, Y. (2026). Tetrahedral DNA Nanostructure‐Based Biomimetic Nanovesicles Attenuate Sepsis‐Associated ARDS by Suppressing Glycolysis via the BMAL1/PFKFB3 Axis. Advanced Science, 13(34). https://doi.org/10.1002/advs.202523782
Vancouver
Zhang Y, Li B, Fan Z, Yan Y, Ma F, He C, et al. Tetrahedral DNA Nanostructure‐Based Biomimetic Nanovesicles Attenuate Sepsis‐Associated ARDS by Suppressing Glycolysis via the BMAL1/PFKFB3 Axis. Advanced Science. 2026;13(34). doi:10.1002/advs.202523782
BibTeX
@article{Zhang2026,
author = {Zhang, Yunlong and Li, Bin and Fan, Zhijin and Yan, Yan and Ma, Fei and He, Changting and Liu, Shiping and Pan, Mingliang and Pan, Zhou and Wang, Huijuan and Fu, Xinting and Wang, Jiamei and Jia, Yue and Gu, Qin and Jiang, Duo and Liu, Xueting and Ren, Bohua and Wang, Qinqin and Hei, Yuehua and Duan, Han and Wu, Yanqiu and Wei, Zihui and Zhan, Liying and Liao, Yuhui},
title = {Tetrahedral DNA Nanostructure‐Based Biomimetic Nanovesicles Attenuate Sepsis‐Associated ARDS by Suppressing Glycolysis via the BMAL1/PFKFB3 Axis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {34},
doi = {10.1002/advs.202523782}
}
EUVIMED